Wednesday, July 8, 2026

pharma · IC - Interstitial Cystitis · Interstitial Cystitis · LIPO

LIPELLA PHARMACEUTICALS

LIPELLA PHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Pittsburgh, USA HQ
2005 Founded
3 Employees
Public company Type
LIPO · NYSE Ticker
Company details
Status
Public
HQ
Pittsburgh, USA
Founded
2005
Employees
3
Programs
4
Drugs
3
Patents
4
Intelligence · Clinical Trials

LIPELLA PHARMACEUTICALS clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to LIPELLA PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

LIPELLA PHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for LIPELLA PHARMACEUTICALS.

  1. LP-10 (Liposomal Tacrolimus) — Phase 2

    Clinical update
  2. LP-08 80mg — Phase 2

    Clinical update
  3. LP-10 — Phase 2

    Clinical update
  4. Ferumoxytol — Phase 1

    Clinical update

Trial registry

4 studies